▎ Ovagen Research
Dab tsi yog qhov kev tshawb fawb keeb kwm ntawm Vesilute?
Hauv kev tshawb nrhiav cov tshuaj bioactive, peptides tau txais kev saib xyuas tseem ceeb vim lawv lub luag haujlwm tseem ceeb hauv ntau cov txheej txheem physiological. Vesilute, ib qho hluavtaws bioactive peptide belongs rau tsev neeg Havensone peptide, nta ib tug tseem ceeb amino acid ib theem zuj zus ntawm Glu-Asp. Kev tshawb fawb pib ntawm Vesilute tau txwv tsis pub dhau. Txawm li cas los xij, muab nws cov qauv zoo sib xws rau Prostamax-lwm Glu-Asp ib ntus-muaj peptide hauv tib tsev neeg-cov kws tshawb fawb tau xav tias nws yuav muaj cov ntaub so ntswg zoo sib xws, yog li pib taug kev ntawm kev tshawb nrhiav tob.
Cov kab mob urinary, xws li mob cystitis thiab benign prostatic hyperplasia, ua rau lub neej tsis zoo, tshwj xeeb tshaj yog cov neeg laus. Vesilute tau tshawb pom los ua kom muaj kev tswj hwm tshwj xeeb ntawm lub zais zis thiab cov ntaub so ntswg prostate. Cov kev tshawb fawb tom qab maj mam nthuav tawm tias nws tuaj yeem cuam tshuam cov kab mob tsis zoo nyob rau hauv cov ntaub so ntswg prostate los ntawm kev cuam tshuam cov noob qhia ntawm qib cellular. Nws hloov kho cov cim tseem ceeb xws li cov ntaub so ntswg o, congestion, thiab cellular infiltration, muab txoj hauv kev tshiab los daws cov teeb meem urological.
Dab tsi yog daim ntawv thov kev kawm ntawm Vesilute?
Targeted Regulation Research for Urinary System Disease
Raws li bioactive regulatory peptide nyob rau hauv tsev neeg Havensone, Vesilute tuav lub hauv paus hauv kev tshawb fawb kab mob urinary system. Nws cov kev tshawb fawb tsom rau cov hnub nyoog ntsig txog mob xws li mob cystitis thiab benign prostatic hyperplasia (BPH), txhim kho prostate microcirculation thiab inhibiting kev txawv txav ntawm tes. Nws txo cov nqaij mos prostate o thiab congestion, txo inflammatory cell infiltration, thiab alleviates urinary dysfunction cov tsos mob xws li nquag tso zis thiab ceev. Qhov kev tswj hwm lub cev tshwj xeeb no tuaj yeem cuam tshuam rau kev tswj hwm epigenetic thiab chromosomal ceev hloov pauv-ib qho kev sib koom tes ntawm tes ntawm Havensone peptides-pab cov kev cuam tshuam tsis yog tshuaj rau cov kab mob urological degenerative.
Expanded Exploration in Fertility and Smooth Muscle Function
Vesilute ua rau pom kev sib txawv ntawm cov nqaij ntshiv ntawm lub cev. Nyob rau hauv kev noj qab haus huv kev ua me nyuam, Lavxias teb sab kev tshawb fawb qhia tias nws txhim kho phev ntau lawm, motility, thiab ib txwm morphology ratios, txhim kho fertility muaj peev xwm los ntawm optimizing cov kab mob cell microenvironment. Nws cov tshuaj tiv thaiv kev sib xyaw ua ke ntawm lub zais zis cov leeg tau nthuav tawm zuj zus, uas muaj feem cuam tshuam rau cov leeg nqaij leeg los ntawm kev tswj hwm glycogen metabolism ntsig txog enzyme kev ua haujlwm - muab kev nkag siab tshiab rau hauv cov txheej txheem molecular ntawm lub zais zis dysmotility.
Xaus
Raws li bioactive regulatory peptide nyob rau hauv tsev neeg Havensone, Vesilute qhia multifaceted kev tshawb fawb daim ntawv thov nrog meej tus nqi. Nyob rau theem tseem ceeb ntawm daim ntawv thov, nws qhia tau hais tias muaj txiaj ntsig zoo hauv kev cuam tshuam cov kab mob urinary. Los ntawm kev tswj cov prostate microcirculation thiab suppressing inflammatory teb, nws alleviates cov ntaub so ntswg o, congestion, thiab urinary dysfunction tshwm sim los ntawm chronic cystitis thiab benign prostatic hyperplasia, muab ib tug tej zaum non-pharmaceutical cuam tshuam mus kom ze rau lub hnub nyoog-hais txog degenerative urinary kab mob uas muaj nyob rau hauv cov neeg laus. Nyob rau hauv kev noj qab haus huv kev ua me nyuam, nws optimizes phev tawm los, motility, thiab morphology ratios, muab txoj kev tshiab rau fertility li kev tshawb fawb. Nws cov kev tswj xyuas cov teebmeem ntawm lub zais zis du cov leeg ua haujlwm tseem muab kev nkag siab rau hauv lub zais zis dysmotility mechanisms.
Los ntawm kev hais txog cov kev xav tau uas tsis tau ntsib hauv urology thiab kev noj qab haus huv ntawm cov menyuam yaus, Vesilute ua rau muaj qhov tsis sib xws hauv kev cuam tshuam cov kab mob, tso cov hauv paus rau kev txhim kho kev nyab xeeb, kev tswj hwm kev daws teeb meem. Nws txhawb kev nkag siab txog cov txheej txheem kev tswj hwm kev noj qab haus huv hauv tsev neeg Havensone peptide, nce kev tshawb fawb tob hauv kev tswj hwm lub cev thiab kev tswj hwm lub cev ntawm cov tshuaj peptide. Qhov no muab qhov tseem ceeb theoretical thiab kev sim hauv paus rau kev txhim kho peptide biopharmaceutical tom ntej, ua lub luag haujlwm tseem ceeb.
Hais Txog Tus Sau
Cov ntaub ntawv hais saum toj no yog txhua yam tshawb fawb, kho thiab sau los ntawm Cocer Peptides.
Tag nrho cov kab lus thiab cov ntaub ntawv ntawm cov khoom lag luam muab rau ntawm lub vev xaib no tsuas yog rau cov ntaub ntawv tshaj tawm kev tshaj tawm thiab cov hom phiaj kev kawm.
Cov khoom muab rau hauv lub vev xaib no yog npaj tshwj xeeb rau kev tshawb fawb hauv vitro. Kev tshawb fawb hauv vitro (Latin: * hauv iav *, lub ntsiab lus hauv iav) yog ua los ntawm tib neeg lub cev. Cov khoom no tsis yog tshuaj, tsis tau txais kev pom zoo los ntawm US Food and Drug Administration (FDA), thiab yuav tsum tsis txhob siv los tiv thaiv, kho, lossis kho txhua yam mob, kab mob, lossis mob. Nws raug txwv nruj raws li txoj cai los qhia cov khoom no rau hauv tib neeg lossis tsiaj lub cev hauv txhua daim ntawv.
